Guardant Health, Inc. is 3.6x more valuable than Caris Life Sciences, Inc. by market capitalization ($17.33 B vs $4.85 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | GH | CAI |
|---|---|---|
| Market cap | $17.33 B | $4.85 B |
| US-listed rank | #671 | #1404 |
| Revenue (latest FY) | $982.02M | $812.03M |
| Net income (latest FY) | -$416.30M | -$68.09M |
| Net margin | -42.4% | -8.4% |
| SEC filings | 1,131 | 102 |
Guardant Health, Inc. is 3.6x more valuable than Caris Life Sciences, Inc. by market capitalization ($17.33 B vs $4.85 B).
In their latest fiscal years, Guardant Health, Inc. reported $982.02M in revenue while Caris Life Sciences, Inc. reported $812.03M.
Full pages: Guardant Health, Inc. and Caris Life Sciences, Inc., or browse the full rankings.